Intratumoral antigen signaling traps CD8 <sup>+</sup> T cells to confine exhaustion to the tumor site
Munetomo Takahashi, Tsz Y. So, Vitalina Chamberlain-Evans, Robert M. Hughes, Juan Carlos Yam‐Puc, Katarzyna Kania, Michelle Ruhle, Tiffeney Mann, Martijn J. Schuijs, Paul Coupland, Dean J. Naisbitt, Timotheus Y.F. Halim, Paul Lyons, Píetro Lió, Rahul Roychoudhuri, Klaus Okkenhaug, David J. Adams, Kenneth G. C. Smith, Duncan I. Jodrell, Michael A. Chapman, James Thaventhiran
Abstract
Immunotherapy advances have been hindered by difficulties in tracking the behaviors of lymphocytes after antigen signaling. Here, we assessed the behavior of T cells active within tumors through the development of the antigen receptor signaling reporter (AgRSR) mouse, fate-mapping lymphocytes responding to antigens at specific times and locations. Contrary to reports describing the ready egress of T cells out of the tumor, we find that intratumoral antigen signaling traps CD8 + T cells in the tumor. These clonal populations expand and become increasingly exhausted over time. By contrast, antigen-signaled regulatory T cell (T reg ) clonal populations readily recirculate out of the tumor. Consequently, intratumoral antigen signaling acts as a gatekeeper to compartmentalize CD8 + T cell responses, even within the same clonotype, thus enabling exhausted T cells to remain confined to a specific tumor tissue site.